Detalhe da pesquisa
1.
Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity.
Small
; 20(10): e2306892, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867244
2.
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*.
Angew Chem Int Ed Engl
; 60(17): 9467-9473, 2021 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464672
3.
Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine.
Angew Chem Int Ed Engl
; 60(31): 16741-16742, 2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278670
4.
Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection.
Respirology
; 24(10): 935-936, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31225681
5.
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice.
Front Immunol
; 15: 1370564, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711520
6.
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice.
bioRxiv
; 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293047
7.
Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586014
8.
A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice.
Res Sq
; 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36711479
9.
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice.
NPJ Vaccines
; 8(1): 96, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386041
10.
RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine.
Front Immunol
; 13: 974016, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426358
11.
Die Another Way: Interplay between Influenza A Virus, Inflammation and Cell Death.
Viruses
; 12(4)2020 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32260457
12.
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine.
bioRxiv
; 2020 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106810
13.
[CRISPR/Cas9 SAM (synergic activation mediator): a new strategy to screen for genome-encoded antiviral restriction factors]. / Utiliser le système CRISPR/Cas9 SAM (synergic activation mediator) pour identifier des facteurs de restriction antiviraux par criblage génomique.
Med Sci (Paris)
; 34(5): 401-403, 2018 May.
Artigo
em Francês
| MEDLINE | ID: mdl-29900840